Nifty
Sensex
:
:
10061.55
34109.54
82.45 (0.83%)
284.01 (0.84%)

Pharmaceuticals & Drugs

Rating :
60/99  (View)

BSE: 532878 | NSE: ALPA

19.50
0.90 (4.84%)
03-Jun-2020 | 3:44PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  19.00
  •  19.50
  •  18.10
  •  18.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  70915
  •  13.83
  •  26.90
  •  11.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 41.13
  • 12.82
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 41.90
  • N/A
  • 0.37

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 56.66%
  • 1.64%
  • 39.64%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 2.06%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -1.88
  • 6.33
  • 7.12

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -7.86
  • -19.38
  • -33.42

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.06
  • -
  • -32.07

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.89
  • 12.11
  • 12.52

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.33
  • 0.33
  • 0.33

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.52
  • 4.37
  • 4.87

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Net Sales
24
26
-7%
24
16
48%
20
0
0
0
0
0
Expenses
22
23
-6%
23
16
42%
19
0
0
0
0
0
EBITDA
2
3
-18%
1
0
1243%
1
0
0
0
0
0
EBIDTM
9%
11%
4%
0%
7%
0%
0%
0%
Other Income
1
1
97%
0
1
-76%
1
0
0
0
0
0
Interest
0
0
-70%
0
0
-77%
0
0
0
0
0
0
Depreciation
1
1
-1%
1
1
-1%
1
0
0
0
0
0
PBT
3
2
6%
0
0
95%
1
0
0
0
0
0
Tax
0
0
-100%
0
0
0
0
0
0
0
0
0
PAT
3
2
8%
0
0
95%
1
0
0
0
0
0
PATM
11%
9%
2%
1%
6%
0%
0%
0%
EPS
1.23
1.13
9%
0.18
0.10
80%
0.58
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
-
78
63
63
54
57
57
Net Sales Growth
-
24%
-1%
18%
-7%
1%
 
Cost Of Goods Sold
-
49
36
36
28
36
32
Gross Profit
-
29
27
27
26
21
25
GP Margin
-
37%
42%
43%
48%
37%
43%
Total Expenditure
-
77
59
56
47
55
51
Power & Fuel Cost
-
2
2
2
1
2
2
% Of Sales
-
3%
3%
2%
3%
3%
4%
Employee Cost
-
12
10
9
7
8
8
% Of Sales
-
15%
16%
14%
13%
13%
14%
Manufacturing Exp.
-
2
2
2
1
2
2
% Of Sales
-
3%
3%
3%
3%
4%
4%
General & Admin Exp.
-
3
2
3
4
3
3
% Of Sales
-
4%
4%
5%
7%
6%
5%
Selling & Distn. Exp.
-
5
4
3
3
3
3
% Of Sales
-
6%
7%
5%
5%
4%
5%
Miscellaneous Exp.
-
4
3
2
3
1
1
% Of Sales
-
5%
4%
3%
5%
2%
2%
EBITDA
-
1
4
7
6
3
6
EBITDA Margin
-
1%
6%
11%
12%
5%
10%
Other Income
-
5
5
5
6
3
1
Interest
-
1
1
2
1
2
2
Depreciation
-
3
3
3
1
6
9
PBT
-
3
5
8
10
-2
-5
Tax
-
2
2
3
3
-1
0
Tax Rate
-
68%
39%
55%
30%
48%
-4%
PAT
-
1
3
3
7
-1
-5
PAT before Minority Interest
-
1
3
3
7
-1
-5
Minority Interest
-
0
0
0
0
0
0
PAT Margin
-
1%
4%
4%
13%
-2%
-9%
PAT Growth
-
-72%
12%
-63%
589%
73%
 
EPS
-
0.38
1.34
1.20
3.26
-0.67
-2.45

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
98
98
95
93
87
88
Share Capital
21
21
21
21
21
21
Total Reserves
77
77
74
72
66
67
Non-Current Liabilities
0
0
0
1
0
6
Secured Loans
0
1
0
0
0
4
Unsecured Loans
0
0
0
0
0
0
Long Term Provisions
0
0
0
0
0
0
Current Liabilities
22
23
30
52
41
32
Trade Payables
13
13
14
19
9
11
Other Current Liabilities
6
4
4
5
2
5
Short Term Borrowings
1
5
10
24
29
16
Short Term Provisions
2
1
2
5
1
1
Total Liabilities
121
121
125
146
128
127
Net Block
8
10
11
15
5
73
Gross Block
39
38
36
35
24
102
Accumulated Depreciation
31
28
25
20
19
29
Non Current Assets
27
23
20
27
16
74
Capital Work in Progress
0
0
0
0
0
0
Non Current Investment
18
13
9
12
10
0
Long Term Loans & Adv.
0
0
0
1
1
1
Other Non Current Assets
0
0
0
0
0
0
Current Assets
94
98
105
119
113
53
Current Investments
30
18
8
0
0
0
Inventories
14
14
13
15
8
13
Sundry Debtors
30
26
29
34
24
20
Cash & Bank
1
21
37
37
72
10
Other Current Assets
19
1
2
11
8
9
Short Term Loans & Adv.
18
18
16
22
7
8
Net Current Assets
72
74
75
66
71
20
Total Assets
121
121
125
146
128
127

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
-2
-13
17
-22
-2
8
PBT
3
5
6
10
-3
-5
Adjustment
1
1
1
0
6
12
Changes in Working Capital
-3
-16
14
-28
-7
1
Cash after chg. in Working capital
1
-11
20
-19
-3
8
Interest Paid
0
0
0
0
0
0
Tax Paid
-2
-2
-3
-3
1
0
Other Direct Exp. Paid
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
Cash From Investing Activity
-14
-11
-2
-8
37
-2
Net Fixed Assets
-1
-2
-1
0
78
Net Investments
-18
-18
-1
-12
-10
Others
4
8
1
4
-30
Cash from Financing Activity
-5
9
-15
-6
7
4
Net Cash Inflow / Outflow
-21
-15
0
-36
42
10
Opening Cash & Equivalents
21
37
37
53
10
1
Closing Cash & Equivalent
1
21
37
17
53
10

Financial Ratios

Standalone /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
47
46
45
44
41
42
ROA
1%
2%
2%
5%
-1%
-4%
ROE
1%
3%
3%
8%
-2%
-6%
ROCE
3%
5%
7%
10%
-1%
-3%
Fixed Asset Turnover
2.03
1.69
1.79
1.96
0.98
0.59
Receivable days
131
160
183
187
132
121
Inventory Days
65
78
81
71
61
79
Payable days
67
88
112
112
64
68
Cash Conversion Cycle
129
150
152
146
128
132
Total Debt/Equity
0.02
0.06
0.11
0.26
0.33
0.26
Interest Cover
5
5
4
8
-1
-1

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.